logo
episode-header-image
May 2021
23m 26s

Why Herd Immunity Is Slipping Away

The New York Times
About this episode

From the earliest days of the pandemic, herd immunity has consistently factored into conversations about how countries can find their way out of lockdowns and restrictions.

Now, many experts believe that the United States may never reach the requisite level of immunity.

We explore why, and what it might look like to live in a country where there is no herd immunity against the coronavirus.

Guest: Apoorva Mandavilli, a science and global health reporter for The New York Times. 

Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter

Background reading: 

  • The emergence of widely circulating coronavirus variants and persistent hesitancy about vaccines will keep the goal out of reach. The virus appears to be here to stay, but vaccinating the most vulnerable may be enough to restore normalcy.

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

Up next
Yesterday
Trump’s Top Aides Spread the Epstein Conspiracy. Now They Are Trying to Kill It.
For months, President Trump and Attorney General Pam Bondi suggested that they would expose the hidden, potentially sinister truth about Jeffrey Epstein’s death in 2019.But over the past few days, the Trump administrationWhite House decided to shut down has poured cold water on t ... Show More
21m 47s
Jul 8
A Love Letter to Camp Mystic
On Monday evening, the death toll from the flooding in Central Texas rose past 100. A single place accounted for 27 of those deaths: Camp Mystic, a century-old Christian summer camp for girls.Erin Paisan, who attended Camp Mystic, explains what the place meant to generations of g ... Show More
25m 9s
Jul 7
A Dark Moment for Journalism — and Devastation in Texas
Last week, when Paramount, the parent company of CBS News, announced a $16 million settlement with President Trump over editing of a segment of “60 Minutes,” many of the network’s journalists were furious.The deal also raised questions about the independence of CBS’s journalism, ... Show More
34m 15s
Recommended Episodes
Jan 2021
Why U.S. Vaccinations Started Slow And What We Know About The New Coronavirus Variant
Initially, U.S. officials predicted that as many as 20 million Americans would be fully vaccinated before the end of 2020. And while that many vaccine doses were distributed, only a fraction of them have been administered. The federal government has given states control over dist ... Show More
12m 21s
Apr 2021
The U.S. Vaccination Rate Continues To Slow
Short Wave's Emily Kwong talks with NPR health correspondent Allison Aubrey about some of the latest coronavirus news, including the return of the Johnson & Johnson vaccine in the U.S. and vaccine outreach in harder to reach communities. Have questions about the latest coronaviru ... Show More
11m 15s
Dec 2020
Vaccine hesitancy, the next pandemic hurdle
As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy. Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ... Show More
31m 47s
Jul 2020
Fauci: U.S. may need to “reset” as virus spirals out of control
As Covid-19 cases continue to rise throughout the South and Southwest of the U.S., White House Task Force Member Dr. Anthony Fauci suggested the country might need to “reset.” At least 27 states have paused or rolled back their re-openings as the U.S. recently saw the highest dai ... Show More
46 m
Feb 2021
Third Vaccine On The Way, Fauci Hails 'Spectacular Results'
A third COVID-19 vaccine could receive emergency use authorization from the Food and Drug Administration this month. The vaccine made by Johnson & Johnson is 66% effective in preventing moderate to severe disease, according to a global study. Combined with the two vaccines curren ... Show More
12m 29s